secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0001493152-24-021456
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce regains Nasdaq compliance with equity requirement, common stock continues trading
--------------------------------------------------------------------------------

- Received notice on May 24, 2024 from Nasdaq of regained compliance with Listing Rule 5550(b)(1) equity requirement.
- Common stock will continue trading on Nasdaq Capital Market tier; delisting risk removed for now.
- Company must maintain all Nasdaq listing requirements going forward; no assurance of future compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224021456/0001493152-24-021456-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224021456/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021456

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer